There have been some recent reports in the news media about this, and patients are asking about the safety of these meds and whether or not they should discontinue them. The link to the FDA safety update as of 3/10/10 is below.
Quote:
|
At this point, the data that FDA has reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
|
Good to know! Please go to the link for more information on this recent report.
It's always interesting to me that a piece of medical information can be picked up by the media and spun around, reported, and the reach and power it has. The implications for patients are significant, creating anxiety and mistrust. Sometimes patients discontinue meds without professional advice, with potentially grave consequences. It's important for NPs and PAs, as patient advocates, to stay updated on the latest information and to use reliable sources.
http://www.fda.gov/Drugs/DrugSafety/.../ucm203891.htm